People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Limerick Biopharma Inc | — | Pharmaceuticals | Series B | $52.8M | $16.3M | 2010 |
Ving Lee at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ving Lee on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kristina Burow | 1 | 16 |
| Corey Goodman | 1 | 13 |
| Chad Waite | 1 | 11 |
| Steve Dow | 1 | 7 |
| Scott Minick | 1 | 7 |
| Stephen Dow | 1 | 4 |
| Corey S. Goodman | 1 | 4 |
| Wendye Robbins | 1 | 3 |
| Asha Rajagopal | 1 | 1 |
| Stephen M. Dow | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.